Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 May 2026 for Maravai Lifesciences Holdings, INC., €7,704. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christine Dolan: trading record in brief
Christine Dolan is a declared insider of Maravai Lifesciences Holdings, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 20 filings cover trades dated from 30 April 2021 to 15 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 22 May 2026, reports a share grant of €7,704 in Maravai Lifesciences Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christine Dolan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
5,006 shares@ US$1.790.0004% mcap2.4% of flowClass A Common StockSEC:0001684273-26-000005:0
28,661 shares@ US$3.0820.6% of flowClass A Common StockSEC:0001684273-26-000003:0
28,934 shares@ US$3.6919.4% of flowClass A Common StockSEC:0001684273-26-000001:0
4,300 shares@ US$1.791.7% of flowClass A Common StockSEC:0001684273-25-000004:0
2,381 shares@ US$1.670.7% of flowClass A Common StockSEC:0001823239-25-000068:0
5,336 shares@ US$2.644.1% of flowClass A Common StockSEC:0001823239-25-000041:0
246,549 sharesClass A Common StockSEC:0001823239-25-000051:0
1,621 shares@ US$4.102.0% of flowClass A Common StockSEC:0001823239-25-000023:0
28,704 shares@ US$4.5640.2% of flowClass A Common StockSEC:0001823239-25-000011:0
1,848 shares@ US$5.703.1% of flowClass A Common StockSEC:0001823239-24-000114:0
483 shares@ US$5.700.8% of flowClass A Common StockSEC:0001823239-24-000053:0
5,383 shares@ US$7.7012.1% of flowClass A Common StockSEC:0001823239-24-000040:0
1,941 shares@ US$5.483.1% of flowClass A Common StockSEC:0001823239-24-000024:0
189,604 sharesClass A Common StockSEC:0001823239-24-000006:0
1,729 shares@ US$5.833.0% of flowClass A Common StockSEC:0001823239-23-000095:0
1,394 shares@ US$11.724.7% of flowClass A Common StockSEC:0001823239-23-000066:0
55,775 sharesClass A Common StockSEC:0001823239-23-000027:0
1,956 shares@ US$15.238.8% of flowClass A Common StockSEC:0001823239-23-000010:0
666 shares@ US$22.954.6% of flowClass A Common StockSEC:0001823239-22-000027:0
916 shares@ US$22.953.6% of flowClass A Common StockSEC:0000899243-22-003414:0
20 of 20 declarations
